Laparoscopic insertion of an inactive implant for gastro-oesophageal reflux disease Interventional procedure consultation Interventional procedures guidance 12 December 2024 Zilucoplan for treating ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

It recommends healthcare practitioners should offer a low-dose combination of inhaled corticosteroids (ICS) and formoterol to be taken as needed for everyone aged 12 and over with newly diagnosed ...

This summary report is based on the NICE assumptions used in the resource impact template. Users can amend the 'Inputs and eligible population' and 'Unit costs' worksheets in the template to reflect ...

These tools set cookies that store anonymised information about how you got to the site, and how you interact with the site.

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

See recommendations on pharmacological management in people aged 12 and over and the summary of pharmacological management in people aged 12 years and over in the BTS, NICE and SIGN guideline on ...

According to the study, technologies that received scientific advice took a median of 312 days to progress from marketing ...

Teclistamab for treating relapsed and refractory multiple myeloma after 3 or more treatments TA1015 13 November 2024 13 November 2024 ...

Eplontersen (Wainzua, AstraZeneca) is indicated for 'treatment of hereditary transthyretin-mediated amyloidosis (ATTRv amyloidosis) in adult patients with stage 1 and 2 polyneuropathy'. The list price ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.